DSIP: Molecular Structure

Molecular Structure and Properties#

DSIP (Delta Sleep-Inducing Peptide) is a linear nonapeptide with the amino acid sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. It has a molecular weight of approximately 849 Da and the molecular formula C35H48N10O15. DSIP is classified as an amphiphilic peptide, meaning it possesses both hydrophilic and hydrophobic regions, a property that influences its interactions with biological membranes and its distribution in the body.

Amino Acid Sequence#

The nonapeptide sequence WAGGDASGE contains several notable features:

• Tryptophan (Trp/W) at position 1: Provides the hydrophobic N-terminal anchor and the primary UV chromophore for spectrophotometric detection at 280 nm
• Alanine residues at positions 2 and 6: Small, non-polar amino acids providing backbone flexibility
• Glycine residues at positions 3, 4, and 8: The glycine-rich central region (Gly-Gly) provides maximum backbone flexibility
• Aspartate (Asp) at position 5: Introduces a negative charge at physiological pH, contributing to the amphiphilic character
• Serine at position 7: Polar uncharged residue with potential for phosphorylation
• Glutamate (Glu) at position 9: C-terminal acidic residue providing additional negative charge

At physiological pH, DSIP carries a net negative charge due to the ionization of Asp5, Glu9, and the C-terminal carboxylate. This charge distribution contributes to the peptide's amphiphilic character, with the hydrophobic tryptophan at the N-terminus and the negatively charged residues distributed toward the C-terminus.

Physicochemical Properties#

Conformational Properties#

DSIP is a flexible peptide in solution due to its high glycine content (three of nine residues). NMR studies suggest that DSIP does not adopt a single stable three-dimensional structure in aqueous solution but rather exists as an ensemble of rapidly interconverting conformations. The tryptophan residue at the N-terminus may interact transiently with aromatic residues in membrane environments, contributing to the peptide's amphiphilic behavior.

The flexibility of DSIP may be functionally significant, as it could allow the peptide to adopt different conformations when interacting with different binding partners, potentially explaining its pleiotropic biological effects across multiple physiological systems.

Pharmacokinetics#

Plasma Half-Life#

Free DSIP in plasma has a very short half-life of approximately 7-8 minutes, reflecting rapid degradation by plasma peptidases. However, a significant fraction of circulating DSIP is bound to a carrier protein (possibly a member of the immunoglobulin superfamily), which extends the functional half-life. The bound form of DSIP may serve as a circulating reservoir that is gradually released.

Circadian Variation#

Plasma DSIP concentrations exhibit marked diurnal variation in humans and other mammals. Concentrations are lowest in the morning hours and peak in the late afternoon and evening, correlating inversely with cortisol levels and positively with body temperature. This circadian pattern suggests regulation by the central circadian clock and may be functionally relevant to the sleep-wake cycle.

Blood-Brain Barrier#

DSIP has been reported to cross the blood-brain barrier, though the mechanism and efficiency of this transport are debated. Some studies suggest active transport, while others propose passive diffusion facilitated by the amphiphilic character of the peptide. The degree of CNS penetration following peripheral administration remains a subject of investigation.

Metabolism#

DSIP is degraded in plasma primarily by aminopeptidases and endopeptidases. The major metabolic pathway involves sequential removal of amino acids from the N-terminus. The tryptophan-alanine bond appears to be a primary cleavage site. In contrast to many bioactive peptides, DSIP may retain partial biological activity through some of its metabolic fragments.

Stability and Storage#

DSIP is relatively unstable in biological fluids due to rapid enzymatic degradation. As a lyophilized powder, DSIP is stable when stored at -20 degrees C protected from light and moisture. Reconstituted solutions should be used promptly or stored frozen in aliquots to prevent degradation. The peptide is susceptible to oxidation of the tryptophan residue, which can be minimized by storage under inert gas and protection from UV light.

Strategies to improve DSIP stability have included the development of analogs with D-amino acid substitutions, N-terminal modifications, and the use of cyclization. These modifications generally extend the biological half-life but may alter the pharmacological profile of the peptide.

Related Reading#

• DSIP overview and research guide
• Peptides similar to DSIP
• DSIP research evidence